Przegląd Menopauzalny

Abstract

4/2021 vol. 20
Review paper

Endometriosis and gynaecological cancers: molecular insights behind a  complex machinery

  1. Department of Pathology, University of Louisville, Louisville, KY, United States
  2. Institute of Sexology, First Faculty of Medicine, Charles University, Prague, Czech Republic
  3. Department of Obstetrics and Gynocology, Azienda Ospedaliera Universitaria Integrata Verona, Italy
  4. Department of Women and Children's Health, University of Padua, Padua, Italy
  5. Department of Medicine, School of Medicine, Nazarbayev University, Nur-Sultan, Kazakhstan
  6. Clinical Academic Department of Women's Health, National Research Center of Mother and Child Health, University Medical Center, Nur-Sultan, Kazakhstan
  7. Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
  8. Department of Obstetrics and Gynecology, "Filippo Del Ponte" Hospital, University of Insubria, Varese, Italy
Menopause Rev 2021; 20(4): 201-206
Online publish date: 2021/12/06
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Endometriosis is described as the presence of both endometrial glandular and stromal cells outside the uterine cavity. A major characterization of this disease is ectopic implantation of endometrial cells with increased migration. It is one of the leading causes of morbidity among premenopausal women, with a prevalence of 10–16% of women of reproductive age. Despite over century of intensive research, none of the current treatment options represents a real cure. Based on the current knowledge, endometriosis, particularly its atypical version, is considered to be a transitional form from benign disease to tumour. However, the exact mechanisms of this conversion are still not fully established.
Share
without publication fees